85 related articles for article (PubMed ID: 32097194)
1. Brief Report: HIV-Associated Hodgkin Lymphoma Involving the Bone Marrow Identifies a Very High-Risk Subpopulation in the Era of Widescale Antiretroviral Therapy Use in Johannesburg, South Africa.
Vaughan J; Perner Y; McAlpine E; Wiggill T
J Acquir Immune Defic Syndr; 2020 Apr; 83(4):345-349. PubMed ID: 32097194
[TBL] [Abstract][Full Text] [Related]
2. Hodgkin lymphoma at Groote Schuur Hospital, South Africa: the effect of HIV and bone marrow infiltration.
Swart L; Novitzky N; Mohamed Z; Opie J
Ann Hematol; 2019 Feb; 98(2):381-389. PubMed ID: 30397846
[TBL] [Abstract][Full Text] [Related]
3. Changing Patterns of Lymphoma in the Antiretroviral Therapy Era in Johannesburg, South Africa.
Wiggill T; Mayne E; Perner Y; Vaughan J
J Acquir Immune Defic Syndr; 2021 Nov; 88(3):252-260. PubMed ID: 34354010
[TBL] [Abstract][Full Text] [Related]
4. Plasmablastic lymphoma in Johannesburg, South Africa, in the era of widescale antiretroviral therapy use.
Vaughan J; Perner Y; Mayne E; Wiggill T
HIV Med; 2021 Mar; 22(3):225-230. PubMed ID: 33022825
[TBL] [Abstract][Full Text] [Related]
5. Diffuse Large B-Cell Lymphoma in the Public-Sector of Johannesburg, South Africa, in the Era of Widescale Antiretroviral Therapy Use.
Vaughan J; Perner Y; Wiggill T
J Acquir Immune Defic Syndr; 2022 Dec; 91(4):335-342. PubMed ID: 35916644
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics of human immunodeficiency virus-associated Hodgkin lymphoma patients in Japan.
Yotsumoto M; Hagiwara S; Ajisawa A; Tanuma J; Uehira T; Nagai H; Fujikawa Y; Maeda S; Kitano K; Arima N; Uno K; Iwai T; Hongo I; Ota Y; Fukutake K; Okada S
Int J Hematol; 2012 Aug; 96(2):247-53. PubMed ID: 22752537
[TBL] [Abstract][Full Text] [Related]
7. HIV-1-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4⁺ T-cell lymphocytes.
Bohlius J; Schmidlin K; Boué F; Fätkenheuer G; May M; Caro-Murillo AM; Mocroft A; Bonnet F; Clifford G; Paparizos V; Miro JM; Obel N; Prins M; Chêne G; Egger M;
Blood; 2011 Jun; 117(23):6100-8. PubMed ID: 21368291
[TBL] [Abstract][Full Text] [Related]
8. Hodgkin lymphoma in HIV positive patients.
Mounier N; Spina M; Spano JP
Curr HIV Res; 2010 Mar; 8(2):141-6. PubMed ID: 20163350
[TBL] [Abstract][Full Text] [Related]
9. Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988-1998.
Glaser SL; Clarke CA; Gulley ML; Craig FE; DiGiuseppe JA; Dorfman RF; Mann RB; Ambinder RF
Cancer; 2003 Jul; 98(2):300-9. PubMed ID: 12872349
[TBL] [Abstract][Full Text] [Related]
10. CD4+ and CD8+ T-cell kinetics in aviremic HIV-infected patients developing Hodgkin or non-Hodgkin lymphoma.
Hoffmann C; Schommers P; Wolf E; Müller M; Schultze A; Krznaric I; Stoehr A; Wolf T; Fäktenheuer G; Stier B; Wyen C; Hentrich M
AIDS; 2016 Mar; 30(5):753-60. PubMed ID: 26605513
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics, incidence, and risk factors of HIV-related Hodgkin lymphoma in the era of combination antiretroviral therapy.
Gotti D; Danesi M; Calabresi A; Ferraresi A; Albini L; Donato F; Castelli F; Scalzini A; Quiros-Roldan E;
AIDS Patient Care STDS; 2013 May; 27(5):259-65. PubMed ID: 23600703
[TBL] [Abstract][Full Text] [Related]
12. Incidence of Hodgkin lymphoma in HIV-positive and HIV-negative patients at a tertiary hospital in South Africa (2005 - 2016) and comparison with other African countries.
Naidoo N; Abayomi A; Locketz C; Musaigwa F; Grewal R
S Afr Med J; 2018 Jun; 108(7):653-567. PubMed ID: 30004343
[TBL] [Abstract][Full Text] [Related]
13. Hodgkin lymphoma is as common as non-Hodgkin lymphoma in HIV-positive patients with sustained viral suppression and limited immune deficiency: a prospective cohort study.
Hoffmann C; Hentrich M; Gillor D; Behrens G; Jensen B; Stoehr A; Esser S; van Lunzen J; Krznaric I; Müller M; Oette M; Hensel M; Thoden J; Fätkenheuer G; Wyen C
HIV Med; 2015 Apr; 16(4):261-4. PubMed ID: 25252101
[TBL] [Abstract][Full Text] [Related]
14. Changing pattern of lymphoma subgroups at a tertiary academic complex in a high-prevalence HIV setting: a South African perspective.
Wiggill TM; Mantina H; Willem P; Perner Y; Stevens WS
J Acquir Immune Defic Syndr; 2011 Apr; 56(5):460-6. PubMed ID: 21239997
[TBL] [Abstract][Full Text] [Related]
15. Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin Lymphoma.
Shepherd L; Ryom L; Law M; Hatleberg CI; de Wit S; Monforte AD; Battegay M; Phillips A; Bonnet F; Reiss P; Pradier C; Grulich A; Sabin C; Lundgren J; Mocroft A
J Natl Cancer Inst; 2018 Jun; 110(6):598-607. PubMed ID: 29267895
[TBL] [Abstract][Full Text] [Related]
16. Managing HIV and Hodgkin lymphoma in the twenty-first century.
Aries J; Montoto S
Curr Hematol Malig Rep; 2014 Sep; 9(3):227-32. PubMed ID: 24906351
[TBL] [Abstract][Full Text] [Related]
17. Incidence, Treatment, and Outcome of HIV-Associated Hematologic Malignancies in People Living with HIV in Sweden.
Kieri O; Marrone G; Sönnerborg A; Nowak P
AIDS Res Hum Retroviruses; 2022 Feb; 38(2):135-142. PubMed ID: 34652958
[TBL] [Abstract][Full Text] [Related]
18. Isolated bone marrow manifestation of HIV-associated Hodgkin lymphoma.
Ponzoni M; Fumagalli L; Rossi G; Freschi M; Re A; Viganò MG; Guidoboni M; Dolcetti R; McKenna RW; Facchetti F
Mod Pathol; 2002 Dec; 15(12):1273-8. PubMed ID: 12481007
[TBL] [Abstract][Full Text] [Related]
19. Changes in elevated cholesterol in the era of tenofovir in South Africa: risk factors, clinical management and outcomes.
Jamieson L; Evans D; Brennan AT; Moyo F; Spencer D; Mahomed K; Maskew M; Long L; Rosen S; Fox MP
HIV Med; 2017 Sep; 18(8):595-603. PubMed ID: 28332270
[TBL] [Abstract][Full Text] [Related]
20. Characterization of HIV-associated Hodgkin's lymphoma in HIV-infected patients: a single-center experience.
Ruiz M; Parsons C; Cole J
J Int Assoc Physicians AIDS Care (Chic); 2012; 11(4):234-8. PubMed ID: 22302202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
